Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFTS vs placebo for pain in acute ankle sprains
2024-513063-45-00Phase 3Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Ankle sprain comparing Esflurbiprofen Topical System with Placebo patch (2 arms). Primary endpoint: Sum of Pain Intensity Difference (SPID) of VAS score on pain-on-movement over 0-48 hours. Started Mar 2025; status: completed.
02
Drugs
esflurbiprofen
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2024-513063-45-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513063-45-00.